Shanghai Junshi (China) Performance
688180 Stock | 29.36 0.77 2.56% |
On a scale of 0 to 100, Shanghai Junshi holds a performance score of 9. The entity has a beta of -0.22, which indicates not very significant fluctuations relative to the market. As returns on the market increase, returns on owning Shanghai Junshi are expected to decrease at a much lower rate. During the bear market, Shanghai Junshi is likely to outperform the market. Please check Shanghai Junshi's downside deviation, standard deviation, and the relationship between the semi deviation and coefficient of variation , to make a quick decision on whether Shanghai Junshi's existing price patterns will revert.
Risk-Adjusted Performance
9 of 100
Weak | Strong |
OK
Compared to the overall equity markets, risk-adjusted returns on investments in Shanghai Junshi Biosciences are ranked lower than 9 (%) of all global equities and portfolios over the last 90 days. Despite somewhat weak basic indicators, Shanghai Junshi sustained solid returns over the last few months and may actually be approaching a breakup point. ...more
1 | Junshi Biosciences Major Shareholders Plan to Reduce Stakes - TipRanks | 09/24/2024 |
2 | Shanghai Junshi Biosciences Faces Board Vacancy - TipRanks | 10/23/2024 |
3 | Shanghai Junshi Biosciences Proposes New Board Members - TipRanks | 11/29/2024 |
Begin Period Cash Flow | 3 B |
Shanghai |
Shanghai Junshi Relative Risk vs. Return Landscape
If you would invest 2,314 in Shanghai Junshi Biosciences on September 22, 2024 and sell it today you would earn a total of 622.00 from holding Shanghai Junshi Biosciences or generate 26.88% return on investment over 90 days. Shanghai Junshi Biosciences is generating 0.4627% of daily returns and assumes 3.9117% volatility on return distribution over the 90 days horizon. Simply put, 34% of stocks are less volatile than Shanghai, and 91% of all equity instruments are likely to generate higher returns than the company over the next 90 trading days. Expected Return |
Risk |
Shanghai Junshi Market Risk Analysis
Today, many novice investors tend to focus exclusively on investment returns with little concern for Shanghai Junshi's investment risk. Standard deviation is the most common way to measure market volatility of stocks, such as Shanghai Junshi Biosciences, and traders can use it to determine the average amount a Shanghai Junshi's price has deviated from the expected return over a period of time. It is calculated by determining the expected price for the established period and then subtracting this figure from each price point. The differences are then squared, summed, and averaged to produce the variance.
Sharpe Ratio = 0.1183
Best Portfolio | Best Equity | |||
Good Returns | ||||
Average Returns | ||||
Small Returns | 688180 | |||
Cash | Small Risk | Average Risk | High Risk | Huge Risk |
Negative Returns |
Estimated Market Risk
3.91 actual daily | 34 66% of assets are more volatile |
Expected Return
0.46 actual daily | 9 91% of assets have higher returns |
Risk-Adjusted Return
0.12 actual daily | 9 91% of assets perform better |
Based on monthly moving average Shanghai Junshi is performing at about 9% of its full potential. If added to a well diversified portfolio the total return can be enhanced and market risk can be reduced. You can increase risk-adjusted return of Shanghai Junshi by adding it to a well-diversified portfolio.
Shanghai Junshi Fundamentals Growth
Shanghai Stock prices reflect investors' perceptions of the future prospects and financial health of Shanghai Junshi, and Shanghai Junshi fundamentals are critical determinants of its market performance. Overall, investors pay close attention to revenue and earnings growth, profit margins, and debt levels. These fundamentals can have a significant impact on Shanghai Stock performance.
Return On Equity | -0.27 | ||||
Return On Asset | -0.11 | ||||
Profit Margin | (1.01) % | ||||
Operating Margin | (0.57) % | ||||
Current Valuation | 24.25 B | ||||
Shares Outstanding | 765.58 M | ||||
Price To Book | 4.45 X | ||||
Price To Sales | 13.99 X | ||||
Revenue | 1.5 B | ||||
Gross Profit | 1.45 B | ||||
EBITDA | (1.61 B) | ||||
Net Income | (2.25 B) | ||||
Total Debt | 539.39 M | ||||
Book Value Per Share | 28.15 X | ||||
Cash Flow From Operations | (2.01 B) | ||||
Earnings Per Share | (1.97) X | ||||
Total Asset | 11.36 B | ||||
Retained Earnings | (9.04 B) | ||||
About Shanghai Junshi Performance
By analyzing Shanghai Junshi's fundamental ratios, stakeholders can gain valuable insights into Shanghai Junshi's financial health, operational efficiency, and overall profitability, helping them make informed investment and management decisions. For instance, if Shanghai Junshi has a high ROA and ROE, it suggests that the company is efficiently using its assets and equity to generate substantial profits, making it an attractive investment. Conversely, if Shanghai Junshi has a low ROA and ROE, it may indicate underlying issues in asset and equity management, signaling a need for operational improvements.
Shanghai Junshi is entity of China. It is traded as Stock on SHG exchange.Things to note about Shanghai Junshi Bios performance evaluation
Checking the ongoing alerts about Shanghai Junshi for important developments is a great way to find new opportunities for your next move. Stock alerts and notifications screener for Shanghai Junshi Bios help investors to be notified of important events, changes in technical or fundamental conditions, and significant headlines that can affect investment decisions.Shanghai Junshi Bios had very high historical volatility over the last 90 days | |
The company reported the revenue of 1.5 B. Net Loss for the year was (2.25 B) with profit before overhead, payroll, taxes, and interest of 1.45 B. | |
Shanghai Junshi generates negative cash flow from operations | |
About 30.0% of the company shares are owned by insiders or employees | |
Latest headline from news.google.com: Shanghai Junshi Biosciences Proposes New Board Members - TipRanks |
- Analyzing Shanghai Junshi's financial statements, including its income statement, balance sheet, and cash flow statement, helps in understanding its overall financial health and growth potential.
- Getting a closer look at valuation ratios like price-to-earnings (P/E) ratio, price-to-sales (P/S) ratio, and price-to-book (P/B) ratio help in understanding whether Shanghai Junshi's stock is overvalued or undervalued compared to its peers.
- Examining Shanghai Junshi's industry or sector and how it is performing can give you an idea of its growth potential and how it is positioned relative to its competitors.
- Evaluating Shanghai Junshi's management team can have a significant impact on its success or failure. Reviewing the track record and experience of Shanghai Junshi's management team can help you assess the Company's leadership.
- Pay attention to analyst opinions and ratings of Shanghai Junshi's stock. These opinions can provide insight into Shanghai Junshi's potential for growth and whether the stock is currently undervalued or overvalued.
Complementary Tools for Shanghai Stock analysis
When running Shanghai Junshi's price analysis, check to measure Shanghai Junshi's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Shanghai Junshi is operating at the current time. Most of Shanghai Junshi's value examination focuses on studying past and present price action to predict the probability of Shanghai Junshi's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Shanghai Junshi's price. Additionally, you may evaluate how the addition of Shanghai Junshi to your portfolios can decrease your overall portfolio volatility.
Money Managers Screen money managers from public funds and ETFs managed around the world | |
Equity Forecasting Use basic forecasting models to generate price predictions and determine price momentum | |
Price Ceiling Movement Calculate and plot Price Ceiling Movement for different equity instruments | |
Companies Directory Evaluate performance of over 100,000 Stocks, Funds, and ETFs against different fundamentals |